Argan INC Form 4 insider transactions
NYSE
AGX
Argan INCRichard H. Deily, Compliance Officer and former CFO of Argan Inc., sold 1,565 shares of common stock on April 30, 2025.
NYSE
AGX
Argan INCCharles Collins IV, CEO of Argan Inc., reports the vesting of restricted stock units and the grant of new stock options and restricted stock units based on time, renewable energy projects, total stock return, and earnings per share performance.
NYSE
AGX
Argan INCDirector Rainer H. Bosselmann reports the vesting of time-based and performance-based restricted stock units, resulting in the acquisition of Argan Inc. common stock.
NYSE
AGX
Argan INCDavid Watson, President and CEO of Argan Inc., reports stock sales, vesting of restricted stock units, and grants of new restricted stock units and stock options.
NYSE
AGX
Argan INCDirector Peter W. Getsinger exercised stock options and sold shares of Argan Inc. common stock in a series of transactions on April 14 and April 16, 2025.
NYSE
AGX
Argan INCWilliam F. Griffin Jr., a director and Non-Executive Chairman (GEMMA) of Argan Inc., transferred 130,000 shares of common stock to the William F. Griffin 2025 GRAT Trust on April 10, 2025.
NYSE
AGX
Argan INCRainer H. Bosselmann, a director at Argan Inc. (AGX), sold 25,000 shares of common stock at an average price of $129.35 per share on April 1, 2025.
NYSE
AGX
Argan INCDirector Cynthia Flanders sold 4,092 shares of Argan Inc. (AGX) on April 2, 2025, at an average price of $133.64 per share.
NYSE
AGX
Argan INCJames W. Quinn, a director of Argan Inc., transferred 63,014 shares of common stock to the James W. Quinn 2025 GRAT No.1 on March 17, 2025.
NYSE
AGX
Argan INCWilliam F. Leimkuhler, a director at Argan Inc., exercised stock options to purchase 10,000 shares of common stock at $30.44 per share on January 21, 2025, using the net settle method, resulting in changes to his beneficial ownership.
NYSE
AGX
Argan INCJohn R. Jeffrey, Jr., a director at Argan Inc., exercised stock options to purchase 10,000 shares of common stock at $40.15 per share on January 17, 2025.
NYSE
AGX
Argan INCDirector Peter W. Getsinger exercised stock options and sold shares of Argan Inc. common stock in a series of transactions in January 2025.
NYSE
AGX
Argan INCRichard H. Deily, Compliance Officer and former CFO of Argan Inc., sold 2,000 shares of the company's common stock on January 8, 2025.
NYSE
AGX
Argan INCArgan Inc. director, Jeffrey John Ronald Jr., sold 5,000 shares of common stock on the open market at an average price of $138.99 per share.
NYSE
AGX
Argan INCDirector Peter W. Getsinger reported donating a total of 2,000 shares of Argan Inc. (AGX) common stock on December 24, 2024.
NYSE
AGX
Argan INCJohn R. Jeffrey, Jr., a director at Argan Inc., exercised stock options to purchase 10,000 shares of common stock at $41.19 per share on December 20, 2024.
NYSE
AGX
Argan INCArgan Inc.'s CEO, David Watson, exercised stock options, sold shares on the open market, and gifted shares to a foundation on December 18, 2024.
NYSE
AGX
Argan INCDirector William F. Leimkuhler of Argan Inc. reported the vesting of restricted stock units and the acquisition of common stock on December 14, 2024.
NYSE
AGX
Argan INCDirector Karen Sweeney of Argan Inc. was granted 388 time-based restricted stock units (TRSUs) that will vest on June 10, 2025.
NYSE
AGX
Argan INCDirector John R. Jeffrey Jr. of Argan Inc. reports the vesting of restricted stock units and a new grant of restricted stock units.
NYSE
AGX
Argan INCDirector Cynthia Flanders of Argan Inc. reports the vesting of restricted stock units and the acquisition of common stock on December 14, 2024.
NYSE
AGX
Argan INCDirector Peter W. Getsinger of Argan Inc. reports the vesting of restricted stock units and the acquisition of common stock on December 14, 2024.
NYSE
AGX
Argan INCDirector James W. Quinn of Argan Inc. reports the vesting of restricted stock units and the acquisition of common stock on December 14, 2024.
NYSE
AGX
Argan INCA Form 4 filing reveals changes in beneficial ownership of Argan Inc. stock and derivative securities held by the estate of deceased director, W.G. Champion Mitchell.
NYSE
AGX
Argan INCDirector Peter W. Getsinger reported a transfer of 1,000 shares of Argan Inc. common stock to a donor advised fund on October 31, 2024.
NYSE
AGX
Argan INCWilliam F. Griffin Jr., a director at Argan Inc., reported that the Peach Pit Foundation, of which his wife is the trustee, sold 7,500 shares of Argan Inc. common stock.
NYSE
AGX
Argan INCWilliam F. Griffin Jr., a director at Argan Inc., reports donating 5,000 shares of Argan Inc. common stock to the Peach Pit Foundation.
NYSE
AGX
Argan INCDirector Rainer H. Bosselmann reports selling shares of Argan Inc. (AGX) common stock over three days in October 2024.
NYSE
AGX
Argan INCDirector Cynthia Flanders sold 5,000 shares of Argan Inc. (AGX) common stock on September 25, 2024, at an average price of $96.3888.
NYSE
AGX
Argan INCDirector Rainer H. Bosselmann exercised stock options to purchase Argan Inc. common stock at various prices on September 23, 2024.